NIHON CHOUZAI Co., Ltd.

Based in Tokyo, Japan, NIHON CHOUZAI Co. , Ltd. is engaged in pharmaceutical services, operating a network of pharmacies and offering health management solutions, including online consultations and medication tracking tools. NIHON CHOUZAI Co.

, Ltd. specializes in delivering comprehensive pharmaceutical and healthcare services through its extensive pharmacy network across Japan. Founded in 1980 in Tokyo, Japan, the company has not undergone any significant strategic pivots or changes. It has successfully completed 2 major deals, with the most recent occurring on September 24, 2025, when Advantage Partners and LYFE Capital acquired a 27.

20% minority stake for JPY 9. 10 billion in a Public to Private transaction. The total amount raised by the company amounts to JPY 85. 72 billion.

Nihon Chouzai Co. , Ltd. specializes in a comprehensive range of pharmaceutical and healthcare services primarily delivered through its network of pharmacies across Japan. The company’s core offerings include traditional pharmacy services, online medication consultations via its NiCOMS platform, and advanced health management tools such as the "Oyakusuri Techou Plus" medication management app.

These products are designed to address various healthcare needs, including effective management of prescriptions, medication adherence, and preventive health check-ups. Nihon Chouzai serves a diverse customer base, including individual patients, healthcare providers, and insurance companies, effectively catering to end users throughout Japan's metropolitan and regional markets. The firm operates nationally, with services available in major urban centers and rural areas alike, ensuring accessibility for all demographics. Nihon Chouzai generates revenue through a combination of direct-to-consumer pharmacy sales, online subscription services for health consultations, and partnerships with healthcare institutions.

Clients typically engage with the firm by utilizing its pharmacy services for prescription fulfillment and health consultations, creating a consistent flow of transactions. The pricing structure for its flagship services is designed to be competitive within the healthcare market, offering consumers various plans that may include one-time consultations or ongoing subscription models for health management. Key products such as the "Oyakusuri Techou Plus" app and the online consultation platform NiCOMS are instrumental in driving revenue, as they provide users with streamlined access to pharmaceutical expertise and health-related support. Through these avenues, Nihon Chouzai establishes a robust transactional framework that caters to both individual consumers and institutional clients.

In September 2025, Nihon Chouzai Co. , Ltd. will utilize the funds from the recent acquisition to bolster its growth strategy in pharmacy-related businesses. This strategy will focus on mergers and acquisitions, enhancing operational efficiency, governance, profitability, human resources optimization, and leadership development.

Additionally, the company plans to expand its service offerings and reach into new markets, leveraging its existing platforms to introduce new products tailored to evolving healthcare needs.